The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias-Reference-Cited by-同舟云学术

The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias

Published:2011-01 Issue:1 Volume:71 Page:70-74
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Minegishi Yuji,Sudoh Junko,Kuribayasi Hideaki,Mizutani Hideki,Seike Masahiro,Azuma Arata,Yoshimura Akinobu,Kudoh Shoji,Gemma Akihiko

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Cryptogenic fibrosing alveolitis and lung cancer;Turner-Warwick;Thorax,1980

2. Clinical deterioration in patients with idiopathic pulmonary fibrosis: caused and assessment;Panos;Am J Med,1990

3. Lung cancer and cryptogenic fibrosing alveolitis. Population-based cohort study;Hubbard;Am J Respir Crit Care Med,2000

4. Lung cancer in patients with idiopathic pulmonary fibrosis;Park;Eur Respir J,2001

5. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias;American Thoracic Society/European Respiratory Society;Am J Respir Crit Care Med,2002

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy;Scientific Reports;2024-05-03

2. Challenges in the Management of Lung Cancer in ILD;Archivos de Bronconeumología;2024-05

3. Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis;Cancers;2024-04-29

4. Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis;Annals of the American Thoracic Society;2024-04

5. Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia;ERJ Open Research;2024-01-11